Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-02-25 @ 5:27 PM
Study NCT ID:
NCT00494234
Status:
COMPLETED
Last Update Posted:
2024-01-19
First Post:
2007-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Neoplasms | View |